Matches in SemOpenAlex for { <https://semopenalex.org/work/W569820218> ?p ?o ?g. }
Showing items 1 to 82 of
82
with 100 items per page.
- W569820218 endingPage "9" @default.
- W569820218 startingPage "135" @default.
- W569820218 abstract "We retrospectively reviewed the medical records of patients with metastatic clear cell renal cell carcinoma who received molecular targeted therapy between 2005 and 2011. Cancer-specific survival was analyzed using the Kaplan-Meier method. Predictors of cancer-specific survival were analyzed using the Cox regression hazards model. A total of 89 patients, consisting of 50 first line patients and 39 patients receiving prior cytokine were included in the analysis. The two-year cancer-specific survival rate of the firstlinegroup was 60.2% and that of theprior cytokinethe rapy group was 62.1%. In univariateanalysis, Karnofsky performance status (KPS)＜80%, time from diagnosis to treatment less than one year, bone metastasis and C-reactive protein (CRP)＞1.3 mg/dl in were statistically significant prognostic factors (p＜0.05). In multivariate analysis, time from diagnosis to treatment less than one year (HR 2.46, 95%CI 1.11-5.82, p＝0.025) and CRP (HR 4.92, 95%CI 2.23-11.3, p＜0.001) were independent prognostic factors. Time from diagnosis to treatment less than one year and CRP were independent prognostic factors in patients who received molecular targeted therapy." @default.
- W569820218 created "2016-06-24" @default.
- W569820218 creator A5005941825 @default.
- W569820218 creator A5006054960 @default.
- W569820218 creator A5008639301 @default.
- W569820218 creator A5020030902 @default.
- W569820218 creator A5025155417 @default.
- W569820218 creator A5037711521 @default.
- W569820218 creator A5037980779 @default.
- W569820218 creator A5039892623 @default.
- W569820218 creator A5043005697 @default.
- W569820218 creator A5048417686 @default.
- W569820218 creator A5079271785 @default.
- W569820218 creator A5082779674 @default.
- W569820218 creator A5083918280 @default.
- W569820218 creator A5085285704 @default.
- W569820218 date "2015-04-01" @default.
- W569820218 modified "2023-09-23" @default.
- W569820218 title "[Prognostic factors and efficacy of molecular targeted therapy for metastatic clear cell renal cell carcinoma]." @default.
- W569820218 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/26037671" @default.
- W569820218 hasPublicationYear "2015" @default.
- W569820218 type Work @default.
- W569820218 sameAs 569820218 @default.
- W569820218 citedByCount "0" @default.
- W569820218 crossrefType "journal-article" @default.
- W569820218 hasAuthorship W569820218A5005941825 @default.
- W569820218 hasAuthorship W569820218A5006054960 @default.
- W569820218 hasAuthorship W569820218A5008639301 @default.
- W569820218 hasAuthorship W569820218A5020030902 @default.
- W569820218 hasAuthorship W569820218A5025155417 @default.
- W569820218 hasAuthorship W569820218A5037711521 @default.
- W569820218 hasAuthorship W569820218A5037980779 @default.
- W569820218 hasAuthorship W569820218A5039892623 @default.
- W569820218 hasAuthorship W569820218A5043005697 @default.
- W569820218 hasAuthorship W569820218A5048417686 @default.
- W569820218 hasAuthorship W569820218A5079271785 @default.
- W569820218 hasAuthorship W569820218A5082779674 @default.
- W569820218 hasAuthorship W569820218A5083918280 @default.
- W569820218 hasAuthorship W569820218A5085285704 @default.
- W569820218 hasConcept C121608353 @default.
- W569820218 hasConcept C126322002 @default.
- W569820218 hasConcept C143998085 @default.
- W569820218 hasConcept C2776907518 @default.
- W569820218 hasConcept C2777472916 @default.
- W569820218 hasConcept C2777546739 @default.
- W569820218 hasConcept C2779013556 @default.
- W569820218 hasConcept C2781230642 @default.
- W569820218 hasConcept C38180746 @default.
- W569820218 hasConcept C50382708 @default.
- W569820218 hasConcept C71924100 @default.
- W569820218 hasConceptScore W569820218C121608353 @default.
- W569820218 hasConceptScore W569820218C126322002 @default.
- W569820218 hasConceptScore W569820218C143998085 @default.
- W569820218 hasConceptScore W569820218C2776907518 @default.
- W569820218 hasConceptScore W569820218C2777472916 @default.
- W569820218 hasConceptScore W569820218C2777546739 @default.
- W569820218 hasConceptScore W569820218C2779013556 @default.
- W569820218 hasConceptScore W569820218C2781230642 @default.
- W569820218 hasConceptScore W569820218C38180746 @default.
- W569820218 hasConceptScore W569820218C50382708 @default.
- W569820218 hasConceptScore W569820218C71924100 @default.
- W569820218 hasIssue "4" @default.
- W569820218 hasLocation W5698202181 @default.
- W569820218 hasOpenAccess W569820218 @default.
- W569820218 hasPrimaryLocation W5698202181 @default.
- W569820218 hasRelatedWork W1975124061 @default.
- W569820218 hasRelatedWork W1998259048 @default.
- W569820218 hasRelatedWork W2121485678 @default.
- W569820218 hasRelatedWork W2367759171 @default.
- W569820218 hasRelatedWork W3018143780 @default.
- W569820218 hasRelatedWork W4223420353 @default.
- W569820218 hasRelatedWork W4246070242 @default.
- W569820218 hasRelatedWork W4250577720 @default.
- W569820218 hasRelatedWork W4252476369 @default.
- W569820218 hasRelatedWork W569820218 @default.
- W569820218 hasVolume "61" @default.
- W569820218 isParatext "false" @default.
- W569820218 isRetracted "false" @default.
- W569820218 magId "569820218" @default.
- W569820218 workType "article" @default.